EQUITY RESEARCH MEMO

AdhexPharma

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)40/100

AdhexPharma is a private French CDMO founded in 2007, headquartered in Lyon, specializing in transdermal patches and oral films. With over 40 years of combined industry heritage, the company provides full-service contract development and manufacturing, from R&D to commercial production, producing more than 180 million units annually. Its expertise in innovative drug delivery systems positions it as a specialized partner for pharmaceutical companies seeking alternative delivery routes. Despite steady operations, the company's growth trajectory and financial performance are not publicly disclosed, making it a lower-profile entity in the CDMO space.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)